M1095-HS-303: A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with moderate to severe hidradenitis suppurativa

sonelokimab (M1095) - Avillion, MoonLake Immunotherap

Feb 18, 2026